FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W156743206> ?p ?o ?g. }

• W156743206 endingPage "1954" @default.
• W156743206 startingPage "1945" @default.
• W156743206 abstract "The purpose of the study was to systematically evaluate the significance of platelet reactivity on clopidogrel treatment on adverse cardiovascular events using a collaborative meta-analysis using patient-level data for the VerifyNow P2Y12 assay (Accumetrics, San Diego, California).Clinical evidence has been controversial regarding the influence of clopidogrel on treatment platelet reactivity and ischemic outcomes.MEDLINE, Scopus, and the Cochrane library databases were searched through January 2010. A database containing individual patient-level time-to-event data was generated from identified studies. The primary outcome of interest was a composite of death, myocardial infarction (MI), or stent thrombosis. Secondary outcomes included the incidence of: 1) death; 2) MI; and 3) stent thrombosis.A total of 6 studies with 3,059 patients was included. In each study, clopidogrel responsiveness was assessed using the same point-of-care assay after percutaneous coronary intervention. The primary endpoint occurred more frequently in higher quartiles of P2Y(12) reaction unit (PRU) values: quartile I, 5.8%; quartile II, 6.9%; quartile III, 10.9%; quartile IV, 15.8% (p < 0.001). Taking quartile I as referent, the hazard ratios (HRs) for the primary endpoint were as follows: quartile II, HR: 1.13 (95% confidence interval [CI]: 0.72 to 1.78; p = 0.60); quartile III, HR: 1.82 (95% CI: 1.20 to 2.75; p = 0.005); quartile IV, HR: 2.62 (95% CI: 1.78 to 3.87; p < 0.001). On a continuous scale, every 10-U increase in PRU was associated with a significantly higher rate of the primary endpoint (HR: 1.04; 95% CI: 1.03 to 1.06; p < 0.0001). According to receiver-operating characteristic curve analysis, a PRU value of 230 appeared to best predict death, MI, or stent thrombosis (p < 0.001). A PRU value ≥230 was associated with a higher rate of the composite primary endpoint (HR: 2.10; 95% CI: 1.62 to 2.73; p < 0.0001), as well as the individual endpoints of death (HR: 1.66; 95% CI: 1.04 to 2.68; p = 0.04), MI (HR: 2.04; 95% CI: 1.51 to 2.76; p < 0.001), and stent thrombosis (HR: 3.11; 95% CI: 1.50 to 6.46; p = 0.002).In this collaborative meta-analysis, the level of on-treatment platelet reactivity according to the P2Y(12) assay is associated with long-term cardiovascular events after percutaneous coronary intervention, including death, MI, and stent thrombosis." @default.
• W156743206 created "2016-06-24" @default.
• W156743206 creator A5007123733 @default.
• W156743206 creator A5032028897 @default.
• W156743206 creator A5033373672 @default.
• W156743206 creator A5043890607 @default.
• W156743206 creator A5056506041 @default.
• W156743206 creator A5058059529 @default.
• W156743206 creator A5062894543 @default.
• W156743206 creator A5067624028 @default.
• W156743206 creator A5069820090 @default.
• W156743206 creator A5070057174 @default.
• W156743206 creator A5075021097 @default.
• W156743206 date "2011-11-01" @default.
• W156743206 modified "2023-10-10" @default.
• W156743206 title "Impact of Platelet Reactivity on Clinical Outcomes After Percutaneous Coronary Intervention" @default.
• W156743206 cites W1409766979 @default.
• W156743206 cites W18470154 @default.
• W156743206 cites W1974655135 @default.
• W156743206 cites W1979423827 @default.
• W156743206 cites W1980235325 @default.
• W156743206 cites W2000442546 @default.
• W156743206 cites W2005993749 @default.
• W156743206 cites W2068138485 @default.
• W156743206 cites W2088680944 @default.
• W156743206 cites W2090438280 @default.
• W156743206 cites W2112316706 @default.
• W156743206 cites W2130644475 @default.
• W156743206 cites W2140501627 @default.
• W156743206 cites W2145126811 @default.
• W156743206 cites W2148363808 @default.
• W156743206 cites W2149465085 @default.
• W156743206 cites W2157823046 @default.
• W156743206 cites W2157833432 @default.
• W156743206 cites W2161136893 @default.
• W156743206 cites W2165620610 @default.
• W156743206 cites W2169387542 @default.
• W156743206 cites W2616325155 @default.
• W156743206 cites W2887768525 @default.
• W156743206 cites W67811773 @default.
• W156743206 cites W9177793 @default.
• W156743206 doi "https://doi.org/10.1016/j.jacc.2011.06.059" @default.
• W156743206 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22032704" @default.
• W156743206 hasPublicationYear "2011" @default.
• W156743206 type Work @default.
• W156743206 sameAs 156743206 @default.
• W156743206 citedByCount "383" @default.
• W156743206 countsByYear W1567432062012 @default.
• W156743206 countsByYear W1567432062013 @default.
• W156743206 countsByYear W1567432062014 @default.
• W156743206 countsByYear W1567432062015 @default.
• W156743206 countsByYear W1567432062016 @default.
• W156743206 countsByYear W1567432062017 @default.
• W156743206 countsByYear W1567432062018 @default.
• W156743206 countsByYear W1567432062019 @default.
• W156743206 countsByYear W1567432062020 @default.
• W156743206 countsByYear W1567432062021 @default.
• W156743206 countsByYear W1567432062022 @default.
• W156743206 countsByYear W1567432062023 @default.
• W156743206 crossrefType "journal-article" @default.
• W156743206 hasAuthorship W156743206A5007123733 @default.
• W156743206 hasAuthorship W156743206A5032028897 @default.
• W156743206 hasAuthorship W156743206A5033373672 @default.
• W156743206 hasAuthorship W156743206A5043890607 @default.
• W156743206 hasAuthorship W156743206A5056506041 @default.
• W156743206 hasAuthorship W156743206A5058059529 @default.
• W156743206 hasAuthorship W156743206A5062894543 @default.
• W156743206 hasAuthorship W156743206A5067624028 @default.
• W156743206 hasAuthorship W156743206A5069820090 @default.
• W156743206 hasAuthorship W156743206A5070057174 @default.
• W156743206 hasAuthorship W156743206A5075021097 @default.
• W156743206 hasBestOaLocation W1567432061 @default.
• W156743206 hasConcept C126322002 @default.
• W156743206 hasConcept C164705383 @default.
• W156743206 hasConcept C168563851 @default.
• W156743206 hasConcept C203092338 @default.
• W156743206 hasConcept C207103383 @default.
• W156743206 hasConcept C2777849778 @default.
• W156743206 hasConcept C2780400711 @default.
• W156743206 hasConcept C44249647 @default.
• W156743206 hasConcept C45393284 @default.
• W156743206 hasConcept C49059817 @default.
• W156743206 hasConcept C500558357 @default.
• W156743206 hasConcept C68443243 @default.
• W156743206 hasConcept C71924100 @default.
• W156743206 hasConceptScore W156743206C126322002 @default.
• W156743206 hasConceptScore W156743206C164705383 @default.
• W156743206 hasConceptScore W156743206C168563851 @default.
• W156743206 hasConceptScore W156743206C203092338 @default.
• W156743206 hasConceptScore W156743206C207103383 @default.
• W156743206 hasConceptScore W156743206C2777849778 @default.
• W156743206 hasConceptScore W156743206C2780400711 @default.
• W156743206 hasConceptScore W156743206C44249647 @default.
• W156743206 hasConceptScore W156743206C45393284 @default.
• W156743206 hasConceptScore W156743206C49059817 @default.
• W156743206 hasConceptScore W156743206C500558357 @default.
• W156743206 hasConceptScore W156743206C68443243 @default.
• W156743206 hasConceptScore W156743206C71924100 @default.

• next